RxDoctor Payments Data

Pauline Morrow

Longmont, CONPI 1629142484

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,825 of the $5,425 with a category attached, or 88.9%. It is spread thinly across 23 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,254 and has fallen 76.7% since, to $526 in 2025.

$5,425in general payments, 2019–2025

Across 122 payments — averaging $44.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Merz North America, Inc.$917
  • UCB, Inc.$568
  • Galderma Laboratories, L.p.$382
  • Revance Therapeutics, Inc.$323
  • Sanofi$260
  • plus $2K from 17 others

What the payments were for

  • Travel & lodging$60011%
  • Food & beverage$4,82589%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →